Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Incyte ROA 2010-2025 | INCY

Current and historical return on assets (ROA) values for Incyte (INCY) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
  
Incyte ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-03-31 $0.02B $5.75B 0.38%
2024-12-31 $0.03B $5.44B 0.58%
2024-09-30 $0.03B $5.01B 0.54%
2024-06-30 $0.10B $4.66B 1.55%
2024-03-31 $0.75B $7.14B 11.25%
2023-12-31 $0.60B $6.78B 9.50%
2023-09-30 $0.43B $6.39B 7.01%
2023-06-30 $0.37B $6.21B 6.29%
2023-03-31 $0.32B $5.80B 5.77%
2022-12-31 $0.34B $5.84B 6.26%
2022-09-30 $0.88B $5.51B 16.83%
2022-06-30 $0.95B $5.32B 19.38%
2022-03-31 $0.93B $5.05B 20.63%
2021-12-31 $0.95B $4.93B 22.73%
2021-09-30 $0.54B $4.20B 13.96%
2021-06-30 $0.34B $3.91B 9.37%
2021-03-31 $0.48B $3.66B 13.94%
2020-12-31 $-0.30B $3.56B -9.23%
2020-09-30 $-0.34B $3.31B -10.55%
2020-06-30 $-0.19B $3.21B -6.09%
2020-03-31 $-0.38B $2.75B -12.22%
2019-12-31 $0.45B $3.43B 14.45%
2019-09-30 $0.40B $3.22B 13.98%
2019-06-30 $0.31B $2.95B 11.23%
2019-03-31 $0.25B $2.75B 9.77%
2018-12-31 $0.11B $2.65B 4.42%
2018-09-30 $-0.11B $2.52B -4.62%
2018-06-30 $-0.10B $2.40B -4.39%
2018-03-31 $-0.17B $2.31B -7.75%
2017-12-31 $-0.31B $2.30B -15.80%
2017-09-30 $-0.15B $2.37B -8.49%
2017-06-30 $-0.15B $1.64B -9.52%
2017-03-31 $-0.11B $1.61B -6.89%
2016-12-31 $0.10B $1.64B 7.29%
2016-09-30 $0.15B $1.54B 11.83%
2016-06-30 $0.07B $1.42B 6.55%
2016-03-31 $0.05B $1.10B 4.83%
2015-12-31 $0.01B $1.01B 0.64%
2015-09-30 $-0.09B $0.93B -9.77%
2015-06-30 $0.01B $0.93B 1.54%
2015-03-31 $-0.03B $0.86B -4.23%
2014-12-31 $-0.05B $0.80B -6.70%
2014-09-30 $-0.06B $0.79B -7.97%
2014-06-30 $-0.14B $0.68B -23.32%
2014-03-31 $-0.10B $0.67B -20.52%
2013-12-31 $-0.08B $0.63B -20.35%
2013-09-30 $-0.02B $0.36B -6.51%
2013-06-30 $-0.02B $0.33B -6.82%
2013-03-31 $-0.02B $0.33B -4.73%
2012-12-31 $-0.04B $0.33B -14.27%
2012-09-30 $-0.12B $0.30B -38.31%
2012-06-30 $-0.15B $0.31B -45.64%
2012-03-31 $-0.21B $0.29B -58.11%
2011-12-31 $-0.19B $0.33B -47.43%
2011-09-30 $-0.10B $0.37B -22.78%
2011-06-30 $-0.08B $0.42B -17.03%
2011-03-31 $-0.02B $0.46B -4.82%
2010-12-31 $-0.03B $0.49B -6.56%
2010-09-30 $-0.15B $0.47B -28.15%
2010-06-30 $-0.16B $0.49B -30.06%
2010-03-31 $-0.21B $0.50B -44.83%
2009-12-31 $-0.21B $0.71B -55.02%
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $13.114B $4.241B
Incyte Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. The company conducts its European clinical development operations in Geneva, Switzerland. Incyte's lead drug, Jakafi (ruxolitinib), is a first-in-class JAK1/JAK2 inhibitor, approved in the United States for the treatment of patients with polycythemia vera ('PV'),who have had an inadequate response to or are intolerant to hydroxyurea. It is also approved for the treatment of patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-PV MF, and post-essential thrombocythemia MF. The drug is also approved in the United States for treatment of steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric patients aged 12 years or older.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) GB $230.797B 17.23
Amgen (AMGN) US $158.742B 14.22
Gilead Sciences (GILD) US $136.807B 14.21
Vertex Pharmaceuticals (VRTX) US $116.958B 0.00
Bristol Myers Squibb (BMY) US $101.245B 6.78
GSK (GSK) GB $83.746B 10.01
CSL (CSLLY) AU $75.092B 0.00
Regeneron Pharmaceuticals (REGN) US $57.139B 13.87
Alnylam Pharmaceuticals (ALNY) US $40.158B 0.00
Argenex SE (ARGX) NL $35.286B 96.32
BioNTech SE (BNTX) DE $25.619B 0.00
Royalty Pharma (RPRX) US $19.588B 8.28
Biogen (BIIB) US $19.144B 8.26
Insmed (INSM) US $17.983B 0.00
Genmab (GNMSF) DK $14.821B 15.16
Genmab (GMAB) DK $14.633B 16.42
Illumina (ILMN) US $13.761B 26.11
Swedish Orphan Biovitrum (BIOVF) SE $11.389B 29.08
Exelixis (EXEL) US $11.342B 19.25
BioMarin Pharmaceutical (BMRN) US $10.782B 17.51
QIAGEN (QGEN) NL $10.472B 20.38
Ascendis Pharma (ASND) DK $10.434B 0.00
Moderna (MRNA) US $10.314B 0.00
Exact Sciences (EXAS) US $10.096B 0.00
Blueprint Medicines (BPMC) US $8.264B 0.00
Bio-Techne Corp (TECH) US $7.920B 29.54
Verona Pharma American Depositary Share (VRNA) GB $7.849B 0.00
Regencell Bioscience Holdings (RGC) HK $7.744B 0.00
Roivant Sciences (ROIV) GB $7.695B 0.00
Revolution Medicines (RVMD) US $7.561B 0.00
Repligen (RGEN) US $7.164B 80.20
Bio-Rad Laboratories (BIO.B) US $6.805B 23.68
Legend Biotech (LEGN) US $6.768B 0.00
Halozyme Therapeutics (HALO) US $6.651B 12.73
Jazz Pharmaceuticals (JAZZ) IE $6.565B 6.45
Guardant Health (GH) US $6.106B 0.00
TG Therapeutics (TGTX) US $5.717B 150.04
Nuvalent (NUVL) US $5.618B 0.00
Telix Pharmaceuticals (TLX) AU $5.440B 0.00
Axsome Therapeutics (AXSM) US $5.125B 0.00
Zealand Pharma (ZLDPF) DK $4.977B 0.00
ADMA Biologics Inc (ADMA) US $4.968B 37.16
Alkermes (ALKS) IE $4.919B 13.20
Zai Lab (ZLAB) CN $4.523B 0.00
Vaxcyte (PCVX) US $4.458B 0.00
Akero Therapeutics (AKRO) US $4.434B 0.00
Cytokinetics (CYTK) US $4.106B 0.00
PTC Therapeutics (PTCT) US $4.063B 7.07
Rhythm Pharmaceuticals (RYTM) US $4.002B 0.00
Krystal Biotech (KRYS) US $3.961B 30.53
Avidity Biosciences (RNA) US $3.781B 0.00
Merus (MRUS) NL $3.780B 0.00
Arcellx (ACLX) US $3.637B 0.00
ACADIA Pharmaceuticals (ACAD) US $3.633B 31.93
CRISPR Therapeutics AG (CRSP) CH $3.572B 0.00
Sarepta Therapeutics (SRPT) US $3.556B 0.00
Ultragenyx Pharmaceutical (RARE) US $3.544B 0.00
SpringWorks Therapeutics (SWTX) US $3.525B 0.00
Protagonist Therapeutics (PTGX) US $3.494B 75.16
Metsera (MTSR) US $3.087B 0.00
Scholar Rock Holding (SRRK) US $3.081B 0.00
Kymera Therapeutics (KYMR) US $3.058B 0.00
HUTCHMED (China) (HCM) HK $2.946B 0.00
Alvotech (ALVO) LU $2.936B 16.79
Viking Therapeutics (VKTX) US $2.929B 0.00
MoonLake Immunotherapeutics (MLTX) CH $2.830B 0.00
Ascentage Pharma Group - (AAPG) CN $2.745B 0.00
ImmunityBio (IBRX) US $2.710B 0.00
Immunovant (IMVT) US $2.677B 0.00
Xenon Pharmaceuticals (XENE) CA $2.514B 0.00
Mirum Pharmaceuticals (MIRM) US $2.458B 0.00
Apellis Pharmaceuticals (APLS) US $2.367B 0.00
Bavarian Nordic (BVNRY) DK $2.226B 11.76
Arrowhead Pharmaceuticals (ARWR) US $2.174B 0.00
Ligand Pharmaceuticals (LGND) US $2.171B 0.00
Vericel (VCEL) US $2.148B 1422.33
Denali Therapeutics (DNLI) US $2.114B 0.00
Kiniksa Pharmaceuticals (KNSA) GB $2.065B 0.00
Apogee Therapeutics (APGE) US $2.048B 0.00
Twist Bioscience (TWST) US $2.008B 0.00
Agios Pharmaceuticals (AGIO) US $1.986B 0.00
CG Oncology (CGON) US $1.971B 0.00
NovoCure (NVCR) JE $1.957B 0.00
IDEAYA Biosciences (IDYA) US $1.943B 0.00
Belite Bio (BLTE) US $1.896B 0.00
Harmony Biosciences Holdings (HRMY) US $1.893B 12.58
Disc Medicine (IRON) US $1.860B 0.00
Amicus Therapeutics (FOLD) US $1.857B 201.00
Certara (CERT) US $1.786B 33.36
Immunocore Holdings (IMCR) GB $1.742B 0.00
Tarsus Pharmaceuticals (TARS) US $1.718B 0.00
Beam Therapeutics (BEAM) US $1.716B 0.00
Edgewise Therapeutics (EWTX) US $1.609B 0.00
Arcutis Biotherapeutics (ARQT) US $1.601B 0.00
Biohaven (BHVN) US $1.579B 0.00
Adaptive Biotechnologies (ADPT) US $1.568B 0.00
89BIO (ETNB) US $1.520B 0.00
Mesoblast (MESO) AU $1.505B 0.00
GRAIL (GRAL) US $1.486B 0.00
Janux Therapeutics (JANX) US $1.473B 0.00
Vera Therapeutics (VERA) US $1.450B 0.00
Celldex Therapeutics (CLDX) US $1.411B 0.00
ANI Pharmaceuticals (ANIP) US $1.355B 13.96
BGM Group (BGM) CN $1.313B 0.00
Viridian Therapeutics (VRDN) US $1.296B 0.00
Travere Therapeutics (TVTX) US $1.288B 0.00
CureVac (CVAC) DE $1.250B 6.05
Anbio Biotechnology (NNNN) DE $1.246B 0.00
Structure Therapeutics (GPCR) US $1.243B 0.00
Dynavax Technologies (DVAX) US $1.233B 73.36
Liquidia Technologies (LQDA) US $1.205B 0.00
MannKind (MNKD) US $1.128B 23.19
Novavax (NVAX) US $1.124B 2.62
Pacira BioSciences (PCRX) US $1.122B 10.68
Niagen Bioscience (NAGE) US $1.074B 151.44
WAVE Life Sciences (WVE) SG $1.071B 0.00
Spyre Therapeutics (SYRE) US $1.042B 0.00
CorMedix Inc (CRMD) US $0.988B 66.18
Arcus Biosciences (RCUS) US $0.978B 0.00
Geron (GERN) US $0.962B 0.00
AbCellera Biologics (ABCL) CA $0.955B 0.00
Mineralys Therapeutics (MLYS) US $0.933B 0.00
NeoGenomics (NEO) US $0.910B 0.00
Nurix Therapeutics (NRIX) US $0.910B 0.00
Praxis Precision Medicines (PRAX) US $0.902B 0.00
MiMedx (MDXG) US $0.892B 21.57
Syndax Pharmaceuticals (SNDX) US $0.882B 0.00
Zymeworks (ZYME) US $0.882B 0.00
Pharvaris (PHVS) NL $0.873B 0.00
Intellia Therapeutics (NTLA) US $0.861B 0.00
UniQure (QURE) NL $0.840B 0.00
Oculis Holding AG (OCS) CH $0.830B 0.00
Oric Pharmaceuticals (ORIC) US $0.821B 0.00
LENZ Therapeutics (LENZ) US $0.816B 0.00
Cogent Biosciences (COGT) US $0.806B 0.00
Immunome (IMNM) US $0.801B 0.00
ArriVent BioPharma (AVBP) US $0.796B 0.00
Pharming Group (PHGUF) NL $0.795B 0.00
Basilea Pharmaceutica AG (BPMUF) CH $0.760B 0.00
Replimune (REPL) US $0.754B 0.00
Gyre Therapeutics (GYRE) US $0.749B 199.75
Iovance Biotherapeutics (IOVA) US $0.748B 0.00
Immatics (IMTX) DE $0.744B 0.00
Phathom Pharmaceuticals (PHAT) US $0.743B 0.00
Pharming Group (PHAR) NL $0.731B 0.00
Sionna Therapeutics (SION) US $0.723B 0.00
Vir Biotechnology (VIR) US $0.722B 0.00
Trevi Therapeutics (TRVI) US $0.714B 0.00
Anavex Life Sciences (AVXL) US $0.686B 0.00
AnaptysBio (ANAB) US $0.685B 0.00
Arbutus Biopharma (ABUS) US $0.676B 0.00
Day One Biopharmaceuticals (DAWN) US $0.676B 0.00
GH Research (GHRS) IE $0.664B 0.00
Sinovac Biotech (SVA) CN $0.645B 0.00
Stoke Therapeutics (STOK) US $0.630B 14.59
EYEPOINT PHARMACEUTICALS, INC (EYPT) US $0.621B 0.00
Upstream Bio (UPB) US $0.611B 0.00
Bicara Therapeutics (BCAX) US $0.591B 0.00
Dianthus Therapeutics (DNTH) US $0.589B 0.00
Nuvation Bio (NUVB) US $0.589B 0.00
Maze Therapeutics (MAZE) US $0.587B 0.00
Sana Biotechnology (SANA) US $0.584B 0.00
Bicycle Therapeutics (BCYC) GB $0.580B 0.00
Autolus Therapeutics (AUTL) GB $0.564B 0.00
Kura Oncology (KURA) US $0.558B 0.00
Urogen Pharma (URGN) US $0.555B 0.00
Tyra Biosciences (TYRA) US $0.554B 0.00
Keros Therapeutics (KROS) US $0.551B 0.00
Mind Medicine (MindMed) (MNMD) US $0.542B 0.00
Castle Biosciences (CSTL) US $0.541B 36.76
Arvinas (ARVN) US $0.539B 0.00
Fortrea Holdings (FTRE) US $0.535B 14.77
MeiraGTx Holdings (MGTX) US $0.533B 0.00
Opthea (OPT) AU $0.525B 0.00
Ginkgo Bioworks Holdings (DNA) US $0.523B 0.00
Tango Therapeutics (TNGX) US $0.508B 0.00
Cullinan Therapeutics (CGEM) US $0.508B 0.00
Oxford BioMedica (OXBDF) GB $0.494B 0.00
PureTech Health (PRTC) US $0.471B 0.00
REGENXBIO (RGNX) US $0.465B 0.00
Myriad Genetics (MYGN) US $0.464B 0.00
ATyr Pharma (ATYR) US $0.463B 0.00
Celcuity (CELC) US $0.459B 0.00
Septerna (SEPN) US $0.453B 0.00
Precigen (PGEN) US $0.449B 0.00
Abivax SA (ABVX) FR $0.443B 0.00
Mereo BioPharma Group - (MREO) GB $0.439B 0.00
Benitec Biopharma (BNTC) US $0.433B 0.00
Zenas BioPharma (ZBIO) US $0.432B 0.00
Sage Therapeutics (SAGE) US $0.420B 0.00
Erasca (ERAS) US $0.419B 0.00
Tectonic Therapeutic (TECX) US $0.409B 0.00
Rapport Therapeutics (RAPP) US $0.408B 0.00
Cytek Biosciences (CTKB) US $0.408B 0.00
Northwest Biotherapeutics (NWBO) US $0.404B 0.00
Kamada (KMDA) IL $0.396B 23.72
ITeos Therapeutics (ITOS) US $0.389B 0.00
Eton Pharmaceuticals (ETON) US $0.384B 0.00
Checkpoint Therapeutics (CKPT) United States $0.371B 0.00
Fulcrum Therapeutics (FULC) US $0.370B 0.00
Humacyte (HUMA) US $0.368B 0.00
Vigil Neuroscience (VIGL) US $0.367B 0.00
Rezolute (RZLT) US $0.359B 0.00
ADC Therapeutics SA (ADCT) CH $0.355B 0.00
Absci (ABSI) US $0.355B 0.00
Solid Biosciences (SLDB) US $0.350B 0.00
MBX Biosciences (MBX) US $0.347B 0.00
Emergent Biosolutions (EBS) US $0.339B 0.00
Terns Pharmaceuticals (TERN) US $0.339B 0.00
Arcturus Therapeutics Holdings (ARCT) US $0.336B 0.00
Compass Therapeutics (CMPX) US $0.333B 0.00
Inventiva S.A (IVA) FR $0.332B 0.00
Ocugen (OCGN) US $0.330B 0.00
Astria Therapeutics (ATXS) US $0.323B 0.00
Aura Biosciences (AURA) US $0.323B 0.00
Abeona Therapeutics (ABEO) US $0.315B 0.00
Rocket Pharmaceuticals (RCKT) US $0.313B 0.00
Verastem (VSTM) US $0.308B 0.00
Monte Rosa Therapeutics (GLUE) US $0.302B 61.38
Zhengye Biotechnology Holding (ZYBT) CN $0.299B 0.00
Allogene Therapeutics (ALLO) US $0.293B 0.00
Alpha Teknova (TKNO) US $0.293B 0.00
Entrada Therapeutics (TRDA) US $0.288B 9.37
Cidara Therapeutics (CDTX) US $0.287B 0.00
Corvus Pharmaceuticals (CRVS) US $0.286B 0.00
XOMA Royalty (XOMA) US $0.285B 0.00
Olema Pharmaceuticals (OLMA) US $0.285B 0.00
Gossamer Bio (GOSS) US $0.282B 0.00
Neurogene (NGNE) US $0.282B 0.00
Palvella Therapeutics (PVLA) US $0.277B 0.00
Amarin (AMRN) IE $0.274B 0.00
Prothena (PRTA) IE $0.273B 0.00
Annexon (ANNX) US $0.273B 0.00
Cartesian Therapeutics (RNAC) US $0.270B 0.00
Atea Pharmaceuticals (AVIR) US $0.270B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Vanda Pharmaceuticals (VNDA) US $0.266B 0.00
Inozyme Pharma (INZY) US $0.258B 0.00
Candel Therapeutics (CADL) US $0.257B 0.00
Prima BioMed (IMMP) AU $0.254B 0.00
Sagimet Biosciences (SGMT) US $0.254B 0.00
Cardiff Oncology (CRDF) US $0.253B 0.00
DBV Technologies S.A (DBVT) FR $0.249B 0.00
Lifecore Biomedical (LFCR) US $0.249B 0.00
Third Harmonic Bio (THRD) US $0.245B 0.00
Lexicon Pharmaceuticals (LXRX) US $0.243B 0.00
Foghorn Therapeutics (FHTX) US $0.241B 0.00
MaxCyte (MXCT) US $0.234B 0.00
Aardvark Therapeutics (AARD) US $0.233B 0.00
Tvardi Therapeutics (TVRD) US $0.230B 0.00
BioStem Technologies (BSEM) $0.230B 9.35
ACELYRIN, INC (SLRN) United States $0.229B 0.00
Semper Paratus Acquisition (TVGN) US $0.228B 0.00
Instil Bio (TIL) US $0.225B 0.00
CytomX Therapeutics (CTMX) US $0.222B 5.73
Adherex Technologies (FENC) US $0.219B 0.00
Design Therapeutics (DSGN) US $0.218B 0.00
Adocia (ADOCY) FR $0.213B 0.00
Y-mAbs Therapeutics (YMAB) US $0.213B 0.00
Inhibrx Biosciences (INBX) US $0.211B 0.12
ScPharmaceuticals (SCPH) US $0.209B 0.00
GENFIT S.A (GNFT) FR $0.205B 0.00
Monopar Therapeutics (MNPR) US $0.205B 0.00
Kodiak Sciences (KOD) US $0.205B 0.00
I-Mab (IMAB) US $0.203B 0.00
CARGO Therapeutics (CRGX) US $0.202B 0.00
ProQR Therapeutics (PRQR) NL $0.198B 0.00
AC Immune (ACIU) CH $0.196B 0.00
Bright Minds Biosciences (DRUG) US $0.194B 0.00
Prime Medicine (PRME) US $0.192B 0.00
Codexis (CDXS) US $0.185B 0.00
Voyager Therapeutics (VYGR) US $0.183B 0.00
Ventyx Biosciences (VTYX) US $0.182B 0.00
Tiziana Life Sciences (TLSA) GB $0.181B 0.00
INmune Bio (INMB) US $0.177B 0.00
Nuvectis Pharma (NVCT) US $0.176B 0.00
Innate Pharma S.A (IPHA) FR $0.175B 0.00
Eledon Pharmaceuticals (ELDN) US $0.172B 0.00
EnGene Holdings (ENGN) CA $0.170B 0.00
Actuate Therapeutics (ACTU) US $0.170B 0.00
Puma Biotechnology (PBYI) US $0.166B 4.35
Galena Biopharma (SLS) US $0.166B 0.00
Editas Medicine (EDIT) US $0.165B 0.00
BioAge Labs (BIOA) US $0.162B 0.00
Spero Therapeutics (SPRO) US $0.158B 0.00
Anika Therapeutics (ANIK) US $0.157B 0.00
DiaMedica Therapeutics (DMAC) US $0.157B 0.00
Molecular Partners AG (MOLN) CH $0.155B 0.00
Alector (ALEC) US $0.154B 0.00
Alpha Cognition (ACOG) CA $0.150B 0.00
Alumis (ALMS) US $0.148B 0.00
23andMe Holding (MEHCQ) US $0.147B 0.00
Compugen (CGEN) IL $0.146B 0.00
Fate Therapeutics (FATE) US $0.146B 0.00
Kyverna Therapeutics (KYTX) US $0.139B 0.00
Eupraxia Pharmaceuticals (EPRX) CA $0.139B 0.00
Rapt Therapeutics (RAPT) US $0.138B 0.00
Neumora Therapeutics (NMRA) US $0.137B 0.00
Nkarta (NKTX) US $0.132B 0.00
Black Diamond Therapeutics (BDTX) US $0.131B 38.50
Agenus (AGEN) US $0.129B 0.00
Greenwich LifeSciences (GLSI) US $0.123B 0.00
Seer (SEER) US $0.122B 0.00
Elicio Therapeutics (ELTX) US $0.122B 0.00
Cuprina Holdings (Cayman) (CUPR) SG $0.120B 0.00
C4 Therapeutics (CCCC) US $0.119B 0.00
Orchestra BioMed Holdings (OBIO) US $0.118B 0.00
BioHarvest Sciences (BHST) CA $0.118B 0.00
Genelux (GNLX) US $0.115B 0.00
Contineum Therapeutics (CTNM) US $0.115B 0.00
Sangamo Therapeutics (SGMO) US $0.114B 0.00
Theratechnologies (THTX) CA $0.114B 0.00
BeyondSpring (BYSI) US $0.112B 0.00
ANIXA BIOSCIENCES INC (ANIX) US $0.108B 0.00
TuHURA Biosciences (HURA) US $0.107B 0.00
EXoZymes (EXOZ) US $0.107B 0.00
Citius Oncology (CTOR) US $0.105B 0.00
Caribou Biosciences (CRBU) US $0.103B 0.00
OKYO Pharma (OKYO) $0.102B 0.00
Cabaletta Bio (CABA) US $0.101B 0.00
Zentalis Pharmaceuticals (ZNTL) US $0.096B 0.00
Tenaya Therapeutics (TNYA) US $0.096B 0.00
Invivyd (IVVD) US $0.095B 0.00
Coya Therapeutics (COYA) US $0.094B 0.00
HilleVax (HLVX) US $0.093B 0.00
Whitehawk Therapeutics (WHWK) US $0.092B 0.00
Adagene (ADAG) CN $0.092B 0.00
IO Biotech (IOBT) DK $0.089B 0.00
Biomea Fusion (BMEA) US $0.089B 0.00
Nautilus Biotechnology (NAUT) US $0.088B 0.00
Coherus Oncology (CHRS) US $0.088B 0.00
Milestone Pharmaceuticals (MIST) CA $0.088B 0.00
TScan Therapeutics (TCRX) US $0.088B 0.00
Prenetics Global (PRE) HK $0.086B 0.00
Climb Bio (CLYM) US $0.085B 0.00
Pliant Therapeutics (PLRX) US $0.085B 0.00
Entera Bio (ENTX) IL $0.085B 0.00
Jasper Therapeutics (JSPR) US $0.084B 0.00
Zura Bio (ZURA) US $0.082B 0.00
XBiotech (XBIT) US $0.080B 0.00
PDS Biotechnology (PDSB) US $0.080B 0.00
Forte Biosciences (FBRX) US $0.080B 0.00
Immunic (IMUX) US $0.077B 0.00
Cellectis S.A (CLLS) FR $0.074B 0.00
Inovio Pharmaceuticals (INO) US $0.073B 0.00
Elutia (ELUT) US $0.073B 0.00
IGM Biosciences (IGMS) US $0.072B 0.00
Genenta Science S.p.A (GNTA) IT $0.071B 0.00
Immuneering (IMRX) US $0.068B 0.00
Senti Biosciences (SNTI) US $0.068B 0.00
Sutro Biopharma (STRO) US $0.067B 0.00
TELA Bio (TELA) US $0.067B 0.00
Immix Biopharma (IMMX) US $0.066B 0.00
Seres Therapeutics (MCRB) US $0.065B 0.00
Alto Neuroscience (ANRO) US $0.065B 0.00
MediciNova (MNOV) US $0.065B 0.00
Ikena Oncology (IKNA) US $0.065B 0.00
Quince Therapeutics (QNCX) US $0.065B 0.00
Acumen Pharmaceuticals (ABOS) US $0.065B 0.00
Adaptimmune Therapeutics (ADAP) GB $0.064B 0.00
VistaGen Therapeutics (VTGN) US $0.064B 0.00
Skye Bioscience (SKYE) US $0.064B 0.00
Repare Therapeutics (RPTX) CA $0.063B 0.00
Renovaro (RENB) US $0.063B 0.00
Clearside Biomedical (CLSD) US $0.062B 0.00
Adicet Bio (ACET) US $0.062B 0.00
CervoMed (CRVO) US $0.062B 0.00
Akoya Biosciences (AKYA) US $0.061B 0.00
Oncobiologics (OTLK) US $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Adlai Nortye (ANL) KY $0.060B 0.00
Opus Genetics (IRD) US $0.058B 0.00
Anebulo Pharmaceuticals (ANEB) US $0.057B 0.00
Exicure (XCUR) US $0.055B 0.00
Annovis Bio (ANVS) US $0.055B 0.00
Werewolf Therapeutics (HOWL) US $0.055B 0.00
Fortress Biotech (FBIO) US $0.055B 0.00
Kronos Bio (KRON) US $0.054B 0.00
Precision BioSciences (DTIL) US $0.054B 0.00
ZIVO Bioscience (ZIVO) US $0.053B 0.00
Quantum Biopharma (QNTM) CA $0.053B 0.00
Connect Biopharma Holdings (CNTB) US $0.053B 0.00
Oncolytics Biotech (ONCY) CA $0.053B 0.00
InflaRx (IFRX) DE $0.053B 0.00
Atara Biotherapeutics (ATRA) US $0.053B 0.00
Adverum Biotechnologies (ADVM) US $0.051B 0.00
Applied Therapeutics (APLT) US $0.050B 0.00
Kalaris Therapeutics (KLRS) US $0.049B 0.00
VTv Therapeutics (VTVT) US $0.049B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Shattuck Labs (STTK) US $0.048B 0.00
Artiva Biotherapeutics (ARTV) US $0.048B 0.00
RenovoRx (RNXT) US $0.048B 0.00
Aligos Therapeutics (ALGS) US $0.047B 0.00
PepGen (PEPG) US $0.047B 0.00
Mersana Therapeutics (MRSN) US $0.046B 0.00
Cue Biopharma (CUE) US $0.045B 0.00
Celularity (CELU) US $0.042B 0.00
Rein Therapeutics (RNTX) US $0.042B 0.00
Biodexa Pharmaceuticals (BDRX) GB $0.039B 0.00
Alterity Therapeutics - (ATHE) AU $0.039B 0.00
Akari Therapeutics (AKTX) GB $0.038B 0.00
Radiopharm Theranostics - (RADX) AU $0.038B 0.00
Clene (CLNN) US $0.037B 0.00
Barinthus Biotherapeutics (BRNS) GB $0.036B 0.00
OnKure Therapeutics (OKUR) US $0.036B 0.00
Medicus Pharma (MDCX) US $0.035B 0.00
Estrella Immunopharma (ESLA) US $0.035B 0.00
LAVA Therapeutics (LVTX) NL $0.034B 0.00
Pluri (PLUR) IL $0.034B 0.00
Xilio Therapeutics (XLO) US $0.034B 0.00
Kezar Life Sciences (KZR) US $0.034B 0.00
Scilex Holding (SCLX) US $0.034B 0.00
Lantern Pharma (LTRN) US $0.033B 0.00
NeuroSense Therapeutics (NRSN) IL $0.033B 0.00
AN2 Therapeutics (ANTX) US $0.032B 0.00
CAMP4 Therapeutics (CAMP) US $0.031B 0.00
FibroBiologics (FBLG) US $0.031B 0.00
Rani Therapeutics Holdings (RANI) US $0.030B 0.00
ABVC BioPharma (ABVC) US $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Coeptis Therapeutics Holdings (COEP) US $0.029B 0.00
MiNK Therapeutics (INKT) US $0.029B 0.00
Grace Therapeutics (GRCE) CA $0.029B 0.00
Dyadic (DYAI) US $0.028B 0.00
KALA BIO (KALA) US $0.028B 0.00
ALX Oncology Holdings (ALXO) US $0.027B 0.00
Cadrenal Therapeutics (CVKD) US $0.027B 0.00
Dare Bioscience (DARE) US $0.027B 0.00
Curis (CRIS) US $0.026B 0.00
Imunon (IMNN) US $0.025B 0.00
Generation Bio (GBIO) US $0.025B 0.00
Passage Bio (PASG) US $0.024B 0.00
CalciMedica (CALC) US $0.024B 0.00
BioAtla (BCAB) US $0.024B 0.00
Tenax Therapeutics (TENX) US $0.024B 0.00
Boundless Bio (BOLD) US $0.024B 0.00
Vor Biopharma (VOR) $0.023B 0.00
Femasys (FEMY) US $0.023B 0.00
Chemomab Therapeutics (CMMB) IL $0.023B 0.00
Elevation Oncology (ELEV) US $0.023B 0.00
Lisata Therapeutics (LSTA) US $0.022B 0.00
Advanced Biomed (ADVB) US $0.021B 0.00
MIRA Pharmaceuticals (MIRA) US $0.020B 0.00
Q32 Bio (QTTB) US $0.020B 0.00
Ovid Therapeutics (OVID) US $0.020B 0.00
Gelteq (GELS) AU $0.020B 0.00
Longeveron (LGVN) US $0.019B 0.00
NextCure (NXTC) US $0.019B 0.00
Cognition Therapeutics (CGTX) US $0.018B 0.00
Aspire Biopharma Holdings (ASBP) US $0.018B 0.00
Cingulate (CING) US $0.018B 0.00
HOOKIPA Pharma (HOOK) US $0.017B 0.00
Hoth Therapeutics (HOTH) US $0.017B 0.00
Lexaria Bioscience (LEXX) CA $0.017B 0.00
Leap Therapeutics (LPTX) US $0.017B 0.00
Promis Neurosciences (PMN) CA $0.017B 0.00
X4 Pharmaceuticals (XFOR) US $0.016B 0.00
CollPlant Biotechnologies (CLGN) IL $0.016B 0.00
SAB Biotherapeutics (SABS) US $0.016B 0.00
GeoVax Labs (GOVX) US $0.016B 0.00
Beyond Air (XAIR) US $0.015B 0.00
IBio (IBIO) US $0.015B 0.00
Synlogic (SYBX) US $0.015B 0.00
MetaVia (MTVA) US $0.014B 0.00
UNITY Biotechnology (UBX) US $0.014B 0.00
Edesa Biotech (EDSA) CA $0.013B 0.00
Rallybio (RLYB) US $0.013B 0.00
Abpro Holdings (ABP) US $0.013B 0.00
Neuphoria Therapeutics (NEUP) AU $0.013B 0.00
Biorestorative Therapies (BRTX) US $0.013B 0.00
Equillium (EQ) US $0.012B 0.00
Bionano Genomics (BNGO) US $0.012B 0.00
Allarity Therapeutics (ALLR) US $0.012B 0.00
Aytu BioPharma (AYTU) US $0.012B 0.00
Athira Pharma (ATHA) US $0.012B 0.00
Lipella Pharmaceuticals (LIPO) US $0.012B 0.00
Bolt Biotherapeutics (BOLT) US $0.012B 0.00
BRIACELL THERAP (BCTX) CA $0.012B 0.00
BioCardia (BCDA) US $0.011B 0.00
COSCIENS Biopharma (CSCI) CA $0.011B 0.00
Aprea Therapeutics (APRE) US $0.010B 0.00
IMMURON (IMRN) AU $0.010B 0.00
Cyclerion Therapeutics (CYCN) US $0.010B 0.00
BioXcel Therapeutics (BTAI) US $0.009B 0.00
Novogen (KZIA) AU $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.009B 0.00
Moleculin Biotech (MBRX) US $0.009B 0.00
Dogwood Therapeutics (DWTX) US $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) US $0.009B 0.00
LakeShore Biopharma (LSB) CN $0.009B 0.00
GENPREX (GNPX) US $0.008B 0.00
BioAffinity Technologies (BIAF) US $0.008B 0.00
HCW Biologics (HCWB) US $0.008B 0.00
Turnstone Biologics (TSBX) US $0.008B 0.00
Silexion Therapeutics Corp (SLXN) IL $0.008B 0.00
Sensei Biotherapeutics (SNSE) US $0.008B 0.00
Evogene (EVGN) IL $0.007B 0.00
GT Biopharma (GTBP) US $0.007B 0.00
Acurx Pharmaceuticals (ACXP) US $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) US $0.007B 0.00
Sunshine Biopharma (SBFM) US $0.007B 0.00
Eyenovia (EYEN) US $0.007B 0.00
IN8bio (INAB) US $0.007B 0.00
Arcadia Biosciences (RKDA) US $0.007B 0.00
Apollomics (APLM) US $0.007B 0.00
Mainz Biomed (MYNZ) DE $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Biofrontera (BFRI) US $0.006B 0.00
Avalon GloboCare (ALBT) US $0.006B 0.00
Soligenix (SNGX) US $0.006B 0.00
Intensity Therapeutics (INTS) US $0.006B 0.00
Pasithea Therapeutics (KTTA) US $0.006B 0.00
Jade Biosciences (JBIO) US $0.006B 0.00
Creative Medical Technology Holdings (CELZ) US $0.006B 0.00
180 Life Sciences (ATNF) US $0.006B 0.00
Synaptogenix (SNPX) US $0.005B 0.00
Mustang Bio (MBIO) US $0.005B 0.00
Ensysce Biosciences (ENSC) US $0.005B 0.00
Dermata Therapeutics (DRMA) US $0.005B 0.00
Polyrizon (PLRZ) IL $0.004B 0.00
Galecto (GLTO) DK $0.004B 0.00
CNS Pharmaceuticals (CNSP) US $0.004B 0.00
VivoSim Labs (VIVS) US $0.004B 0.00
Titan Pharmaceuticals (TTNP) US $0.004B 0.00
Artelo Biosciences (ARTL) US $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) US $0.004B 0.00
Onconetix (ONCO) US $0.004B 0.00
Tharimmune (THAR) US $0.003B 0.00
Purple Biotech (PPBT) IL $0.003B 0.00
AquaBounty Technologies (AQB) US $0.003B 0.00
ZyVersa Therapeutics (ZVSA) US $0.003B 0.00
Palisade Bio (PALI) US $0.003B 0.00
Lixte Biotechnology Holdings (LIXT) US $0.003B 0.00
Enveric Biosciences (ENVB) US $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
Virax Biolabs Group (VRAX) GB $0.003B 0.00
GRI Bio (GRI) US $0.003B 0.00
Adial Pharmaceuticals (ADIL) US $0.003B 0.00
Silo Pharma (SILO) US $0.003B 0.00
Bone Biologics (BBLG) US $0.003B 0.00
Alzamend Neuro (ALZN) US $0.003B 0.00
Psyence Biomedical (PBM) CA $0.003B 0.00
Entero Therapeutics (ENTO) US $0.002B 0.00
Scinai Immunotherapeutics (SCNI) IL $0.002B 0.00
Windtree Therapeutics (WINT) US $0.002B 0.00
Atrinsic (PTIX) US $0.002B 0.00
Aptevo Therapeutics (APVO) US $0.002B 0.00
Revelation Biosciences (REVB) US $0.001B 0.00
NuCana (NCNA) GB $0.001B 0.00
Capstone Holding� (CAPS) US $0.000B 0.00
Aceragen (ACGN) US $0.000B 0.00
ARAVIVE, INC (ARAV) US $0.000B 0.00
Clovis Oncology (CLVSQ) US $0.000B 0.00
Cocrystal Pharma (COCP) US $0.000B 0.00
Celyad SA (CYAD) BE $0.000B 0.00
CytoMed Therapeutics (GDTC) SG $0.000B 0.00
Galapagos (GLPG) BE $0.000B 0.00
Motif Bio Plc (MTFB) GB $0.000B 0.00
PDL BioPharma (PDLI) US $0.000B 0.00
Pulmatrix (PULM) US $0.000B 0.00
TFF Pharmaceuticals (TFFP) US $0.000B 0.00
VectivBio Holding AG (VECT) CH $0.000B 0.00